Click to Share
 
 
  1. Latest News
  2. Submit Press Release
Filter News
Show All Results
News By Country
News By Tag
Biosimilars Remove
Related Tags


May 2015
Fr Th We Tu Mo Su Sa
29 28 27 26 25 24 23

biosimilars Press Releases

  + XML/RSS  



By Researchmoz.us
Biosimilars Market Analysis - Biosimilars on the cusp of a new era - Global Industry size, share, trend, forecast, Analysis and growth
By SMi Group Ltd
Returning for its fitfth year and following on from the major success of previous events, SMI are proud to present the 5th annual Biosimilars & Biobetters Conference, 29th-30th September, 2014, London.
By Online Compliance Panel LLC
Know the complete details, key strategies, regulatory considerations, and marketing strategies for developing 505(b)(2) products
By Clarkston Consulting
Industry Experts Discuss How Generics Companies Can Successfully Navigate 2014 Trends
By SMI Group
Inaugural Biosimilars and Biobetters USA conference to take place Monday 7th – Tuesday 8th April 2014: Renaissance Woodbridge Hotel, Iselin, NJ
By SMi Group
Biosimilars and Biobetters USA conference to take place Monday 7th – Tuesday 8th April 2014: Renaissance Woodbridge Hotel, Iselin, NJ
By SMi Group
Creating an Innovate Plan for the USA Biosimilars Market: presentations from Sandoz, IMS Health, Bristows, PRA International, Celltrion, MedImmune, Novartis, Lonza Biologics and others
By smi group
SMi's Biosimilars: Commercial Strategies and Regulatory Guidelines masterclass, taking place on the 9 December in London, will address the common pitfalls in and around biosimilar regulatory requirements in both Europe and the US.
By SMi Group
SMi is pleased to announce the 16th annual Generics and Patent Strategies conference taking place in London from 13-14 May 2013. The conference will see world-renowned experts present the hottest topics and key challenges faced within the industry
By engageIndia
engageIndia has partnered with the ultimate global forum on Lifesciences, BioAsia, India to connect, discuss, explore and drive a bio-future poised to be shaped by the next industry trends: Biologics and Biosimilars.
By SMi Group
Variations in global regulatory strategy for biosimilars outside Europe, Japan and the US
By SMi Group
Biosimilars for recombinant human insulin and insulin glargine

All Press Releases

By Visiongain
LONDON, UK. 18th of February 2015: A new report by visiongain forecasts Brazil’s pharmaceuticals market will reach $50.6bn in 2019. That developing country will rise in the world pharma rankings, with fast expansion from 2015 to 2025.
By PharmSource
CMOs must provide value beyond capacity to secure contracts, new PharmSource report says
By Researchmoz.us
Biosimilars Market Analysis - Biosimilars on the cusp of a new era - Global Industry size, share, trend, forecast, Analysis and growth
By SMi Group Ltd
SMi Group reports (2014.08.22, London): In preparation for the 5th annual Biosimilars and Biobetters Conference, SMi Group has conducted a series of interviews with leading industry experts
By SMi Group Ltd
Due to the increasing complexity of bringing biosimilars from the lab to the global market, the increasing number of partnerships in the past year has been on a steep rise.
By SMi Group Ltd
Returning for its fitfth year and following on from the major success of previous events, SMI are proud to present the 5th annual Biosimilars & Biobetters Conference, 29th-30th September, 2014, London.
By Online Compliance Panel LLC
Know the complete details, key strategies, regulatory considerations, and marketing strategies for developing 505(b)(2) products
By Clarkston Consulting
Industry Experts Discuss How Generics Companies Can Successfully Navigate 2014 Trends
By SMI Group
Inaugural Biosimilars and Biobetters USA conference to take place Monday 7th – Tuesday 8th April 2014: Renaissance Woodbridge Hotel, Iselin, NJ
By SMi Group
Biosimilars and Biobetters USA conference to take place Monday 7th – Tuesday 8th April 2014: Renaissance Woodbridge Hotel, Iselin, NJ
By SMi Group
Creating an Innovate Plan for the USA Biosimilars Market: presentations from Sandoz, IMS Health, Bristows, PRA International, Celltrion, MedImmune, Novartis, Lonza Biologics and others
By smi group
SMi's Biosimilars: Commercial Strategies and Regulatory Guidelines masterclass, taking place on the 9 December in London, will address the common pitfalls in and around biosimilar regulatory requirements in both Europe and the US.
By SMi Group
Held in association with Interpharm | 17 July 2013, London,...
By SMi Group
SMi is pleased to announce the 16th annual Generics and Patent Strategies conference taking place in London from 13-14 May 2013. The conference will see world-renowned experts present the hottest topics and key challenges faced within the industry
By engageIndia
engageIndia has partnered with the ultimate global forum on Lifesciences, BioAsia, India to connect, discuss, explore and drive a bio-future poised to be shaped by the next industry trends: Biologics and Biosimilars.
By SMi Group
Variations in global regulatory strategy for biosimilars outside Europe, Japan and the US
By SMi Group
Biosimilars for recombinant human insulin and insulin glargine
By shailaja
BioPharma India- Today to Future 2020 seeks to provide platform for the leaders from Biologics,Biosimilars and Health Management Services to exchange insight towards challenges and opportunities waiting to be converted to the next blockbuster level
By visiongain
A new report by visiongain, a London-based business information company, predicts that global revenues for biosimilars will reach $1.6 billion in 2012.
By Bharatbook
Bharatbook from its exhaustive collection has come out with a report " Biosimilars : Current Situation & Future Prospects, Worldwide " which gives an overview, Demand, Supply Trends and industry analysis reports.
By GTCbio.com
Vice Presidents and Directors of Big Pharmas – Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Janssen, Merck, Novartis, Novo Nordis, Pfizer, Roche, Sanofi and many more will speak at the 2nd Diabetes Summit
By Global Information Inc.
Conferences and exhibitions provide networking opportunities with leaders from all sectors of biotechnology and pharmaceuticals.
By Frost & Sullivan
Seamlessly Integrated R&D, Production, Sales and Marketing Processes to Ensure Success in this High Growth Market
By Frost & Sullivan
Patent Expiry of Several Key Blockbuster Drugs worth $ 150 billion between 2010 and 2017 Sets Stage for Entry of Generics Manufacturers
By Joe Walsh
Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report.
By Shushmul Maheshwari
The biotech market in South Korea is forecasted to grow at a CAGR of around 35% during 2010-2013, says RNCOS in its latest research study.
By Krishna Sharma
A new report from IMARC Group expects the US biosimilar market to reach revenues worth US$ 11.4 Billion by 2020. This market, however, unlike small molecule generics, is expected to be a marathon and not a sprint.
By IMARC Group
Driven by a strong growth in the sales of temperature sensitive healthcare products, IMARC Group expects the global healthcare cold chain logistics market to grow robustly in the coming years.
By SMi Group
With billions of dollars worth of biologic drugs going off patient in the next decade, this industry is set to expand at an intensive rate, and the importance of being fully informed of how you and your business will be affected is paramount.
By RNCOS E-Services Pvt. Ltd.
The South Korean biotech industry is expected to grow at a CAGR of around 35% during 2010-2013, thereby contributing majorly to the Asia Pacific biotech market, says RNCOS in its latest research.
By Shushmul Maheshwari
The Asia Pacific biotech market is expected to grow at a CAGR of around 19% during 2010-2013 on the back of demographic factors and increasing investments in the industry, says RNCOS.
By SMi Group
With billions of dollars worth of biologic drugs going off patient in the next decade, this industry is set to expand at an intensive rate, and the importance of being fully informed of how you and your business will be affected is paramount.
By American Conference Institute
Attend the one event where the industry leaders driving the business of biosimilars unite to set the standards which will shape an evolving legal and regulatory landscape
By Visiongain Ltd.
GPCR & Kinase Targets Advances in drug discovery from molecular to clinical 14th - 15th April 2011, Thistle City Barbican, London, UK
By MarketResearch.com
The report provides extensive information and rational analysis of the global monoclonal antibodies market.
By Fast Market Research
New Pharmaceuticals research report from Business Insights is now available from Fast Market Research
By Aarkstore Enterprise
Aarkstore.com announce a new report "Global Biosimilars (Follow-on biologics) Market: An Analysis " through its vast collection of market research report.
By Bharatbook
Bharatbook added a new report on "Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025" which predicts how the biosimilars market will develop from 2010 onwards.
By Curaxys S.L.
La Cátedra Curaxys se dedicará al desarrollo de medicamentos biológicos, y a la formación de investigadores y gestores especializados en biotecnología
By Visiongain Ltd.
Recently published report Biosimilars and Follow-On Biologics: Global Market Outlook 2010-2025 will provide you with information that you need to understand current trends and future possibilities for those drugs.
By Fast Market Research
Fast Market Research recommends "The Global Active Pharmaceutical Ingredients (API) Market: Evaluating challenges, opportunities, innovations and the market environment" from Business Insights, now available
By PharmaManufacturing.com
How have recent shifts in the health care reform debate changed the outlook of biosimilars legislation, and how could inappropriate legislation stifle the innovation inherent in the biotech industry? The experts weigh in.
By Press Release APSA
A multidisciplinary team of researches specialized on Biotechnology, Biomedicine, Science and Environmental sciences, will research in new processes for the biosimilars production.
By PR Antas Pharma
Un equipo multidisciplinar de la Universidad, de Biotecnología, Ciencias y Medio Ambiente, investigará en productos biogenéricos
By Antas Pharma press division
The biosimilars production has been incorporate to the new technological platforms of Curaxys in order to get more competitive processes and products. Curaxys has been pioneer in the use of those technologies, mainly in the baculovirus expression sys
By APSA Press release. Spain
Curaxys is the new company specialized in the production of biosimilars medicines. It is an independent private company, located on the technological park of Cadiz (Spain). The new venture is focuses in the development of new technological platform f
By Bharatbook
Bharatbook.com added a new report on "Europe Active Pharmaceuticals Ingredients Market Analysis and Forecasts to 2020" focus the Growth Of The Innovative Sector Of The Synthetic API Market In Europe.
By Bharat Book Bureau
Bharatbook.com included " Biosimilars and Biobetters: Positioning for a New Market " that provides information on biosimilars and production of therapeutic peptides and proteins
By Visiongain Ltd.
Monoclonal antibodies in cancer therapy – significant commercial opportunities with developing technologies and innovative products – our new report explains prospects


Page:

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share